Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 5,607 shares at $72.00 ($404K) on 2011-02-04, disclosed to the SEC on 2011-02-08.
Open-market sale of $404k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.00 | 2,694 | $194K | 48.0% |
| 2 | $72.00 | 2,913 | $210K | 52.0% |
| Total | $72.00 avg | 5,607 | $404K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |